Product Name
Collagen Type XVII, aa507-548 (COL17A1), Polyclonal Antibody
Full Product Name
Collagen Type XVII, aa507-548 (BP180, Collagen type XVII alpha 1, COL17A1, 180kD bullous pemphigoid antigen 2, BA16H23.2, BPAG2, Bullous pemphigoid antigen 2, Collagen alpha-1(XVII) chain, FLJ60881, KIAA0204, LAD-1)
Product Synonym Names
Anti -Collagen Type XVII, aa507-548 (BP180, Collagen type XVII alpha 1, COL17A1, 180kD bullous pemphigoid antigen 2, BA16H23.2, BPAG2, Bullous pemphigoid antigen 2, Collagen alpha-1(XVII) chain, FLJ60881, KIAA0204, LAD-1)
Product Gene Name
anti-COL17A1 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 10; NC_000010.10 (105791046..105845638, complement). Location: 10q24.3
3D Structure
ModBase 3D Structure for Q9UMD9
Specificity
Recogizes human Type XVII Collagen.
Purity/Purification
Affinity Purified
Purified Protein G affinity chromatography
Form/Format
Supplied as a lyophilized powder in PBS, pH 7.2. Reconstitute in ddH2O.
Immunogen
Glutathione-S-transferase fusion protein containing the sequence of the immunodominant region (aa507-548) of human type XVII collagen/BP180.
Preparation and Storage
Lyophilized powder may be stored at -20 degree C. Stable for 12 months at -20 degree C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Reconstituted product is stable for 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Other Notes
Small volumes of anti-COL17A1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Product Categories/Family for anti-COL17A1 antibody
Antibodies; Abs to Collagen
Applications Tested/Suitable for anti-COL17A1 antibody
ELISA (EL/EIA), Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
Application Notes for anti-COL17A1 antibody
Suitable for use in ELISA, Immunocytochemistry, Immunohistochemistry and Western Blot.
Dilution: ELISA: 1:5000
Western Blot: 1:500
Immunocytochemistry (Frozen): 1:100
NCBI/Uniprot data below describe general gene information for COL17A1. It may not necessarily be applicable to this product.
UniProt Primary Accession #
Q9UMD9
[Other Products]
UniProt Secondary Accession #
Q02802; Q5JV36; Q99018; Q9NQK9; Q9UC14[Other Products]
UniProt Related Accession #
Q5JV37; Q9UMD9[Other Products]
Molecular Weight
150,419 Da[Similar Products]
NCBI Official Full Name
collagen, type XVII, alpha 1, isoform CRA_b
NCBI Official Synonym Full Names
collagen, type XVII, alpha 1
NCBI Official Symbol
COL17A1 [Similar Products]
NCBI Official Synonym Symbols
BP180; BPAG2; LAD-1; FLJ60881; KIAA0204; BA16H23.2
[Similar Products]
NCBI Protein Information
collagen alpha-1(XVII) chain; collagen alpha-1(XVII) chain; OTTHUMP00000020422; OTTHUMP00000020424; alpha 1 type XVII collagen; collagen XVII, alpha-1 polypeptide; 180 kDa bullous pemphigoid antigen 2; bullous pemphigoid antigen 2 (180kD); bA16H23.2 (collagen, type XVII, alpha 1 (BP180))
UniProt Protein Name
Collagen alpha-1(XVII) chain
UniProt Synonym Protein Names
180 kDa bullous pemphigoid antigen 2; Bullous pemphigoid antigen 2Cleaved into the following 2 chains:120 kDa linear IgA disease antigen; Alternative name(s):; 120 kDa linear IgA dermatosis antigen; Linear IgA disease antigen 1; LAD-197 kDa linear IgA disease antigen; Alternative name(s):; 97 kDa linear IgA bullous dermatosis antigen; 97 kDa LAD antigen; 97-LAD; Linear IgA bullous disease antigen of 97 kDa
UniProt Gene Name
COL17A1 [Similar Products]
UniProt Synonym Gene Names
BP180; BPAG2 [Similar Products]
UniProt Entry Name
COHA1_HUMAN
NCBI Summary for COL17A1
This gene encodes the alpha chain of type XVII collagen. Unlike most collagens, collagen XVII is a transmembrane protein. Collagen XVII is a structural component of hemidesmosomes, multiprotein complexes at the dermal-epidermal basement membrane zone that mediate adhesion of keratinocytes to the underlying membrane. Mutations in this gene are associated with both generalized atrophic benign and junctional epidermolysis bullosa. Two homotrimeric forms of type XVII collagen exist. The full length form is the transmembrane protein. A soluble form, referred to as either ectodomain or LAD-1, is generated by proteolytic processing of the full length form. [provided by RefSeq]
UniProt Comments for COL17A1
COL17A1: May play a role in the integrity of hemidesmosome and the attachment of basal keratinocytes to the underlying basement membrane. Defects in COL17A1 are a cause of generalized atrophic benign epidermolysis bullosa (GABEB). GABEB is a non- lethal, ***** form of junctional epidermolysis bullosa characterized by life-long blistering of the skin, associated with hair and tooth abnormalities. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Extracellular matrix; Membrane protein, integral; Motility/polarity/chemotaxis
Chromosomal Location of Human Ortholog: 10q24.3
Cellular Component: collagen; hemidesmosome; integral to plasma membrane; endoplasmic reticulum lumen; plasma membrane; extracellular region; basement membrane; intercellular junction
Molecular Function: protein binding
Biological Process: collagen catabolic process; extracellular matrix disassembly; epidermis development; extracellular matrix organization and biogenesis; hemidesmosome assembly; cell-matrix adhesion
Disease: Epidermolysis Bullosa, Junctional, Non-herlitz Type
Research Articles on COL17A1
1. Alterations in type I hemidesmosome components (BP180 and BP230) are suggestive of epigenetic control in the salivary glands of patients with Sjogren's syndrome.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.